T3	Subject 122 152	a patient with dermatomyositis
T5	Treatment 43 92	amifostine used with concurrent chemoradiotherapy
T6	Effect 0 39	Life-threatening anaphylactoid reaction
T7	Sub-Disorder 137 152	dermatomyositis
T8	Treat-Disorder 97 118	nasopharyngeal cancer
T9	Drug 43 53	amifostine
T10	Drug 75 92	chemoradiotherapy
T4	Adverse_event 40 42	to
T11	Combination 59 63	with
E1	Adverse_event:T4 
E2	Combination:T11 arg:T9 arg2:T10
T1	Severity_cue 0 16	Life-threatening
A1	Severity E1 High
